stockportfolio.pro
Stocks / CI vs REGN
CI vs REGN
The Cigna Group and Regeneron Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| The Cigna Group (CI) | Regeneron Pharmaceuticals, Inc. (REGN) | |
|---|---|---|
| Market cap | $78.0B | $64.6B |
| Revenue (latest FY) | $274.90B | $14.34B |
| Net income (latest FY) | $5.96B | $4.50B |
| Revenue growth (5y CAGR) | 11.4% | 11.0% |
| Net margin | 2.2% | 31.4% |
| Return on equity | 14.3% | 14.4% |
| P/E ratio | 2.6 | 15.0 |
| Dividend yield | 2.1% | 0.6% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | — | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CI — free Open REGN — freeFrequently asked questions
Which is bigger, CI or REGN?
The Cigna Group is larger by market capitalization — $78.0B versus $64.6B.
Which grows faster, CI or REGN?
Over the last five fiscal years, The Cigna Group grew revenue faster — 11.4%/yr versus 11.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.